Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients

NCT00447967 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]